to view the full document.
throbber
Case 1:21-cv-00612-UNA Document 1 Filed 04/29/21 Page 1 of 11 PageID #: 1
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`MAYNE PHARMA LLC,
`
`
`Plaintiff,
`
`
`
`v.
`
`
`PERRIGO ISRAEL PHARMACEUTICALS
`LTD. and PERRIGO CO. PLC,
`
`
`Defendant.
`
`
`
`C.A. No. ________________
`
`
`
`
`COMPLAINT
`
`Plaintiff Mayne Pharma LLC (“Mayne” or “Plaintiff”), by its undersigned attorneys, brings
`
`this action against Defendants Perrigo Israel Pharmaceuticals Ltd. and Perrigo Company plc
`
`(collectively, “Perrigo” or “Defendants”), and hereby alleges as follows:
`
`NATURE OF ACTION
`
`1.
`
`This is an action for patent infringement of U.S. Patent No. 10,857,159 (the “’159
`
`patent” or “patent-in-suit”) under the patent laws of the United States, Title 35, United States Code
`
`§ 100, et seq. This action arises from Perrigo’s submission of Abbreviated New Drug Application
`
`(“ANDA”) No. 215266 to the U.S. Food and Drug Administration (“FDA”). Through its ANDA,
`
`Perrigo seeks approval to market 0.05% halobetasol propionate topical foam, a generic version of
`
`Mayne’s LEXETTE® drug product (“Perrigo ANDA product”), prior to the expiration of the
`
`patent-in-suit.
`
`2.
`
`This is also an action under 28 U.S.C. §§ 2201–02 for a declaratory judgment of
`
`patent infringement arising under the patent laws of the United States, 35 U.S.C. § 1, et seq., and
`
`in particular under 35 U.S.C. §§ 271(a), (b), and/or (c).
`
`

`

`Case 1:21-cv-00612-UNA Document 1 Filed 04/29/21 Page 2 of 11 PageID #: 2
`
`3.
`
`Mayne is a Delaware limited liability company with a place of business at 1240
`
`THE PARTIES
`
`Sugg Parkway, Greenville, North Carolina 27834.
`
`4.
`
`Upon information and belief, Perrigo Israel Pharmaceuticals Ltd. (“Perrigo Israel”)
`
`is an Israeli corporation with a place of business at 1 Rakefet St., Shoham 608500, Israel.
`
`5.
`
`Upon information and belief, Perrigo Company plc (“Perrigo Ireland”) is an Irish
`
`corporation with a place of business at The Sharp Building, Hogan Place, Dublin 2, Ireland.
`
`6.
`
`Upon information and belief, Perrigo Israel is a wholly-owned subsidiary by
`
`Perrigo Ireland.
`
`7.
`
`Upon information and belief, Perrigo prepared and submitted ANDA No. 215266
`
`and continues to collaborate in seeking FDA approval of that application.
`
`8.
`
`Upon information and belief, Perrigo intends to commercially manufacture, market,
`
`offer for sale, and sell the Perrigo ANDA product throughout the United States, including in the
`
`State of Delaware, in the event the FDA approves ANDA No. 215266.
`
`9.
`
`Upon information and belief, Perrigo Israel manufactures, sells, markets, and
`
`distributes generic pharmaceutical products throughout the United States, including in this district,
`
`in conjunction with or under the direction of Perrigo Ireland.
`
`JURISDICTION AND VENUE
`
`10.
`
`This Court has subject matter jurisdiction pursuant to 28 U.S.C. §§ 1331, 1338,
`
`2201, 2202 because this is a patent infringement action that arises under the patent laws of the
`
`United States, 35 U.S.C. § 100 et seq. and the Declaratory Judgment Act.
`
`11.
`
`This Court has personal jurisdiction over Perrigo Israel because, inter alia, it has
`
`purposefully availed itself of the benefits and protections of Delaware’s laws such that it should
`
`reasonably anticipate being haled into court here. Upon information and belief, Perrigo Israel
`
`2
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket